Related Experiment Video

Updated: Aug 18, 2026

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
09:13

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

Published on: October 24, 2016

Gene therapy of viral hepatitis and hepatocellular carcinoma

J Ruiz1, C Qian, M Drozdzik

  • 1Department of Medicine, Medical School, University of Navarra, Pamplona, Spain.

Journal of Viral Hepatitis
|June 10, 2000
PubMed

Insights

Gene therapy shows promise for treating liver cancer and viral hepatitis, offering new hope where conventional treatments fail. Further research into gene expression and delivery is crucial for its widespread clinical use.

Area of Science:

  • Oncology
  • Hepatology
  • Molecular Biology
  • Immunology

Background:

  • Gene therapy is emerging as a viable treatment for inherited and acquired diseases.
  • Liver cancer and viral hepatitis are significant unmet medical needs due to limited success of current therapies.
  • Gene therapy offers novel strategies for both viral hepatitis and hepatocellular carcinoma.

Purpose of the Study:

  • To explore the potential of gene therapy for treating liver diseases, specifically viral hepatitis and hepatocellular carcinoma.
  • To outline current gene therapy approaches for these conditions.
  • To identify key areas for future research and development.

Main Methods:

  • Review of gene therapy strategies for viral hepatitis, including immune stimulation and blocking viral replication.
  • Analysis of gene transfer techniques for hepatocellular carcinoma, such as suicide gene therapy, genetic immunotherapy, and oncogene inhibition.
  • Discussion of advancements in gene expression, vector design, and gene delivery.

Main Results:

  • Gene therapy approaches for viral hepatitis aim to enhance immune response or confer resistance to infection.
  • Therapeutic strategies for hepatocellular carcinoma encompass drug sensitization, genetic immunotherapy, tumor suppressor gene replacement, oncogene inhibition, and antiangiogenesis.
  • Significant progress has been made in understanding gene regulation and vector development.

Conclusions:

  • Gene therapy presents a promising alternative for liver cancer and viral hepatitis treatment.
  • Current gene therapy applications target viral infections and tumor suppression.
  • Further advancements in gene expression, vector efficiency, and delivery systems are essential for broad clinical application.

More Related Videos

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...